[Form 4] BioAtla, Inc. Insider Trading Activity
Jay M. Short, Chief Executive Officer, Director and reported 10% owner of BioAtla, Inc. (BCAB), filed a Form 4 disclosing a non-sale transaction on 08/31/2025. The filing shows 6,347 shares of Common Stock were withheld by the issuer at a price of $0.4555 to satisfy income tax and withholding obligations related to the vesting and net settlement of previously reported restricted stock units. After the withholding, the reporting person directly beneficially owned 2,243,678 shares. The Form 4 also reports indirect holdings: 793,547 shares held by spouse, two trusts with 258,727 shares each, 302,324 shares by Capia IP, LLC, and 50 shares by Himalaya Parent LLC, where the reporting person and spouse are managers. The filing was signed by an attorney-in-fact on 09/02/2025.
Jay M. Short, Amministratore Delegato, Direttore e segnalato come proprietario del 10% di BioAtla, Inc. (BCAB), ha depositato un Modulo 4 che rivela una transazione non di vendita in data 31/08/2025. Dal documento risulta che 6.347 azioni di Azioni Ordinarie sono state trattenute dall’emittente al prezzo di $0,4555 per coprire imposte sul reddito e ritenute legate alla maturazione e al regolamento netto di unità di azioni vincolate precedentemente segnalate. Dopo la ritenuta, la persona segnalante deteneva direttamente in modo beneficiario 2.243.678 azioni. Il Modulo 4 riporta inoltre partecipazioni indirette: 793.547 azioni detenute dal coniuge, due trust con 258.727 azioni ciascuno, 302.324 azioni da Capia IP, LLC e 50 azioni da Himalaya Parent LLC, di cui la persona segnalante e il coniuge sono amministratori. Il documento è stato firmato da un procuratore il 02/09/2025.
Jay M. Short, Director Ejecutivo, Director y reportado como propietario del 10% de BioAtla, Inc. (BCAB), presentó un Formulario 4 que revela una transacción no relacionada con una venta el 31/08/2025. La presentación indica que 6.347 acciones de Acciones Comunes fueron retenidas por el emisor a un precio de $0.4555 para satisfacer impuestos sobre la renta y retenciones vinculadas a la consolidación y liquidación neta de unidades de acciones restringidas previamente informadas. Tras la retención, la persona informante poseía directamente de forma beneficiaria 2.243.678 acciones. El Formulario 4 también informa participaciones indirectas: 793.547 acciones en poder del cónyuge, dos fideicomisos con 258.727 acciones cada uno, 302.324 acciones por Capia IP, LLC y 50 acciones por Himalaya Parent LLC, donde la persona informante y su cónyuge son administradores. La presentación fue firmada por un apoderado el 02/09/2025.
Jay M. Short는 BioAtla, Inc.(BCAB)의 최고경영자(CEO), 이사이자 보고상 10% 주주로서 2025-08-31자 비매매 거래를 공시한 Form 4를 제출했습니다. 해당 제출서류에 따르면 6,347주의 보통주가 발행사에 의해 원천징수되어 $0.4555의 주당 가격으로 이전에 보고된 제한주식단위(RSU)의 베스팅 및 순결제와 관련한 소득세 및 원천징수 의무를 충당했습니다. 원천징수 후 보고인은 직접적으로 2,243,678주를 실질 소유하고 있었습니다. Form 4는 또한 간접 보유를 보고하는데, 배우자가 보유한 793,547주, 각 258,727주의 두 신탁, 302,324주의 Capia IP, LLC, 및 보고인과 배우자가 매니저로 있는 Himalaya Parent LLC의 50주가 포함되어 있습니다. 해당 서류는 2025-09-02에 대리인이 서명했습니다.
Jay M. Short, directeur général, administrateur et déclaré détenteur de 10% de BioAtla, Inc. (BCAB), a déposé un formulaire 4 révélant une transaction non liée à une vente le 31/08/2025. Le dossier indique que 6 347 actions ordinaires ont été retenues par l’émetteur au prix de 0,4555 $ pour couvrir les impôts sur le revenu et les retenues liés à la consolidation et au règlement net d’unités d’actions restreintes précédemment déclarées. Après cette retenue, la personne déclarant détenait directement à titre bénéficiaire 2 243 678 actions. Le formulaire 4 signale également des détentions indirectes : 793 547 actions détenues par le conjoint, deux trusts de 258 727 actions chacun, 302 324 actions par Capia IP, LLC et 50 actions par Himalaya Parent LLC, dont la personne déclarant et son conjoint sont gestionnaires. Le document a été signé par un mandataire le 02/09/2025.
Jay M. Short, Chief Executive Officer, Direktor und als 10%-Eigentümer von BioAtla, Inc. (BCAB) gemeldet, reichte ein Formular 4 ein, das eine nicht-verkaufsbezogene Transaktion am 31.08.2025 offenlegt. Aus der Einreichung geht hervor, dass 6.347 Aktien des Stammkapitals vom Emittenten einbehalten wurden zu einem Preis von $0,4555, um Einkommenssteuer- und Abzugsverpflichtungen im Zusammenhang mit der Ausübung und Nettoregelung zuvor gemeldeter Restricted Stock Units zu erfüllen. Nach dem Einbehalt hielt die meldende Person direkt wirtschaftlich 2.243.678 Aktien. Das Formular 4 berichtet außerdem über indirekte Beteiligungen: 793.547 Aktien im Besitz des Ehepartners, zwei Treuhandfonds mit jeweils 258.727 Aktien, 302.324 Aktien durch Capia IP, LLC und 50 Aktien durch Himalaya Parent LLC, bei der die meldende Person und der Ehepartner als Manager fungieren. Die Einreichung wurde am 02.09.2025 von einem Bevollmächtigten unterschrieben.
- Transaction is non-sale and tax-related, indicating restricted stock units were settled rather than an open-market disposal
- Comprehensive ownership disclosure listing direct and multiple indirect holdings (spouse, trusts, LLCs) with disclaimers
- None.
Insights
TL;DR: Routine tax withholding from vested RSUs; ownership structure and disclosure are clear and compliant.
The Form 4 documents a withholding of 6,347 Common Stock shares to satisfy tax obligations tied to RSU vesting, not an open-market sale. Such withholdings are common and indicate equity compensation is being settled. The filing clearly lists both direct and multiple categories of indirect ownership, including spouse holdings and trust/LLC interests, and includes the reporting persons roles as CEO, Director, and 10% owner. The signature by an attorney-in-fact is properly noted. From a governance perspective, this is a routine insider reporting event and meets Section 16 disclosure requirements.
TL;DR: Small withholding reduces direct shares marginally; transaction is non-sale and tax-related.
The reported transaction code and explanation specify that shares were withheld by the issuer for tax withholding upon RSU vesting, confirming this was not a market disposition. The number withheld (6,347) at $0.4555 is small relative to the reported direct beneficial ownership of 2,243,678 shares. The report also maps indirect holdings through spouse, trusts, and affiliated entities, with clear disclaimers about beneficial ownership limits. This filing provides transparent detail relevant for tracking insider equity changes.
Jay M. Short, Amministratore Delegato, Direttore e segnalato come proprietario del 10% di BioAtla, Inc. (BCAB), ha depositato un Modulo 4 che rivela una transazione non di vendita in data 31/08/2025. Dal documento risulta che 6.347 azioni di Azioni Ordinarie sono state trattenute dall’emittente al prezzo di $0,4555 per coprire imposte sul reddito e ritenute legate alla maturazione e al regolamento netto di unità di azioni vincolate precedentemente segnalate. Dopo la ritenuta, la persona segnalante deteneva direttamente in modo beneficiario 2.243.678 azioni. Il Modulo 4 riporta inoltre partecipazioni indirette: 793.547 azioni detenute dal coniuge, due trust con 258.727 azioni ciascuno, 302.324 azioni da Capia IP, LLC e 50 azioni da Himalaya Parent LLC, di cui la persona segnalante e il coniuge sono amministratori. Il documento è stato firmato da un procuratore il 02/09/2025.
Jay M. Short, Director Ejecutivo, Director y reportado como propietario del 10% de BioAtla, Inc. (BCAB), presentó un Formulario 4 que revela una transacción no relacionada con una venta el 31/08/2025. La presentación indica que 6.347 acciones de Acciones Comunes fueron retenidas por el emisor a un precio de $0.4555 para satisfacer impuestos sobre la renta y retenciones vinculadas a la consolidación y liquidación neta de unidades de acciones restringidas previamente informadas. Tras la retención, la persona informante poseía directamente de forma beneficiaria 2.243.678 acciones. El Formulario 4 también informa participaciones indirectas: 793.547 acciones en poder del cónyuge, dos fideicomisos con 258.727 acciones cada uno, 302.324 acciones por Capia IP, LLC y 50 acciones por Himalaya Parent LLC, donde la persona informante y su cónyuge son administradores. La presentación fue firmada por un apoderado el 02/09/2025.
Jay M. Short는 BioAtla, Inc.(BCAB)의 최고경영자(CEO), 이사이자 보고상 10% 주주로서 2025-08-31자 비매매 거래를 공시한 Form 4를 제출했습니다. 해당 제출서류에 따르면 6,347주의 보통주가 발행사에 의해 원천징수되어 $0.4555의 주당 가격으로 이전에 보고된 제한주식단위(RSU)의 베스팅 및 순결제와 관련한 소득세 및 원천징수 의무를 충당했습니다. 원천징수 후 보고인은 직접적으로 2,243,678주를 실질 소유하고 있었습니다. Form 4는 또한 간접 보유를 보고하는데, 배우자가 보유한 793,547주, 각 258,727주의 두 신탁, 302,324주의 Capia IP, LLC, 및 보고인과 배우자가 매니저로 있는 Himalaya Parent LLC의 50주가 포함되어 있습니다. 해당 서류는 2025-09-02에 대리인이 서명했습니다.
Jay M. Short, directeur général, administrateur et déclaré détenteur de 10% de BioAtla, Inc. (BCAB), a déposé un formulaire 4 révélant une transaction non liée à une vente le 31/08/2025. Le dossier indique que 6 347 actions ordinaires ont été retenues par l’émetteur au prix de 0,4555 $ pour couvrir les impôts sur le revenu et les retenues liés à la consolidation et au règlement net d’unités d’actions restreintes précédemment déclarées. Après cette retenue, la personne déclarant détenait directement à titre bénéficiaire 2 243 678 actions. Le formulaire 4 signale également des détentions indirectes : 793 547 actions détenues par le conjoint, deux trusts de 258 727 actions chacun, 302 324 actions par Capia IP, LLC et 50 actions par Himalaya Parent LLC, dont la personne déclarant et son conjoint sont gestionnaires. Le document a été signé par un mandataire le 02/09/2025.
Jay M. Short, Chief Executive Officer, Direktor und als 10%-Eigentümer von BioAtla, Inc. (BCAB) gemeldet, reichte ein Formular 4 ein, das eine nicht-verkaufsbezogene Transaktion am 31.08.2025 offenlegt. Aus der Einreichung geht hervor, dass 6.347 Aktien des Stammkapitals vom Emittenten einbehalten wurden zu einem Preis von $0,4555, um Einkommenssteuer- und Abzugsverpflichtungen im Zusammenhang mit der Ausübung und Nettoregelung zuvor gemeldeter Restricted Stock Units zu erfüllen. Nach dem Einbehalt hielt die meldende Person direkt wirtschaftlich 2.243.678 Aktien. Das Formular 4 berichtet außerdem über indirekte Beteiligungen: 793.547 Aktien im Besitz des Ehepartners, zwei Treuhandfonds mit jeweils 258.727 Aktien, 302.324 Aktien durch Capia IP, LLC und 50 Aktien durch Himalaya Parent LLC, bei der die meldende Person und der Ehepartner als Manager fungieren. Die Einreichung wurde am 02.09.2025 von einem Bevollmächtigten unterschrieben.
FAQ
What transaction did Jay M. Short report on Form 4 for BCAB?
Was the reported transaction a sale of BioAtla (BCAB) shares?
How many shares does Jay M. Short beneficially own after the transaction?
What indirect holdings are reported for Jay M. Short on this Form 4?
When was the Form 4 signed and by whom?
